Biosurgery Market Size, Share, and Trends 2025 to 2034

The global biosurgery market is projected to grow from USD 18.09 billion in 2025 to approximately USD 37.29 billion by 2034, registering a CAGR of 8.35% during the forecast period. In 2024, bone graft substitutes led the product segment with a 41% share, while anti-adhesive agents are expected to grow at a CAGR of 12.1%. Neuro and spine surgeries accounted for over 37% of application revenue, with general surgery poised for the fastest growth. Biologics represented 63% of the market by source, and hospitals dominated end-user share with 76%.ce of bone graft substitutes, rapid adoption of anti-adhesive agents, and strong growth across neuro, spine, and general surgery applications.

Last Updated : June 2025  |  Report Code : 3610  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biosurgery Market 

5.1. COVID-19 Landscape: Biosurgery Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biosurgery Market, By Product Type

8.1. Biosurgery Market Revenue and Volume, by Product Type

8.1.1 Anti-Adhesive Agents

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Bone Graft Substitutes

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Hemostatic and Surgical Sealant

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Mesh

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Biosurgery Market, By Application

9.1. Biosurgery Market Revenue and Volume, by Application

9.1.1. Cardiovascular and Thoracic Surgery

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Neuro and Spine Surgery

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Orthopedic Surgery

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. General Surgery

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Biosurgery Market, By Source 

10.1. Biosurgery Market Revenue and Volume, by Source

10.1.1. Biologics Products

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Synthetic Products

10.1.2.1. Market Revenue and Volume Forecast

Chapter 11. Global Biosurgery Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type

11.1.2. Market Revenue and Volume Forecast, by Application

11.1.3. Market Revenue and Volume Forecast, by Source

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type

11.1.4.2. Market Revenue and Volume Forecast, by Application

11.1.4.3. Market Revenue and Volume Forecast, by Source

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type

11.1.5.2. Market Revenue and Volume Forecast, by Application

11.1.5.3. Market Revenue and Volume Forecast, by Source

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type

11.2.2. Market Revenue and Volume Forecast, by Application

11.2.3. Market Revenue and Volume Forecast, by Source

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type

11.2.4.2. Market Revenue and Volume Forecast, by Application

11.2.4.3. Market Revenue and Volume Forecast, by Source

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type

11.2.5.2. Market Revenue and Volume Forecast, by Application

11.2.5.3. Market Revenue and Volume Forecast, by Source

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type

11.2.6.2. Market Revenue and Volume Forecast, by Application

11.2.6.3. Market Revenue and Volume Forecast, by Source

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type

11.2.7.2. Market Revenue and Volume Forecast, by Application

11.2.7.3. Market Revenue and Volume Forecast, by Source

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type

11.3.2. Market Revenue and Volume Forecast, by Application

11.3.3. Market Revenue and Volume Forecast, by Source

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type

11.3.4.2. Market Revenue and Volume Forecast, by Application

11.3.4.3. Market Revenue and Volume Forecast, by Source

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type

11.3.5.2. Market Revenue and Volume Forecast, by Application

11.3.5.3. Market Revenue and Volume Forecast, by Source

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type

11.3.6.2. Market Revenue and Volume Forecast, by Application

11.3.6.3. Market Revenue and Volume Forecast, by Source

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type

11.3.7.2. Market Revenue and Volume Forecast, by Application

11.3.7.3. Market Revenue and Volume Forecast, by Source

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.2. Market Revenue and Volume Forecast, by Application

11.4.3. Market Revenue and Volume Forecast, by Source

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.4.2. Market Revenue and Volume Forecast, by Application

11.4.4.3. Market Revenue and Volume Forecast, by Source

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type

11.4.5.2. Market Revenue and Volume Forecast, by Application

11.4.5.3. Market Revenue and Volume Forecast, by Source

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type

11.4.6.2. Market Revenue and Volume Forecast, by Application

11.4.6.3. Market Revenue and Volume Forecast, by Source

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type

11.4.7.2. Market Revenue and Volume Forecast, by Application

11.4.7.3. Market Revenue and Volume Forecast, by Source

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.2. Market Revenue and Volume Forecast, by Application

11.5.3. Market Revenue and Volume Forecast, by Source

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type

11.5.4.2. Market Revenue and Volume Forecast, by Application

11.5.4.3. Market Revenue and Volume Forecast, by Source

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.5.2. Market Revenue and Volume Forecast, by Application

11.5.5.3. Market Revenue and Volume Forecast, by Source

Chapter 12. Company Profiles

12.1. Johnson & Johnson

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Baxter International Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Medtronic plc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. B. Braun Melsungen AG

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Integra LifeSciences Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. C.R. Bard, Inc. (Acquired by BD)

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Sanofi

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Pfizer Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Stryker Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Cohera Medical, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global biosurgery market size is expected to increase USD 37.29 billion by 2034 from USD 16.72 billion in 2024.

The global biosurgery market will register a growth rate of 8.35% between 2025 and 2034.

The major players operating in the biosurgery market are Johnson & Johnson, Baxter International Inc., Medtronic plc, B. Braun Melsungen AG, Integra LifeSciences Corporation, C.R. Bard, Inc. (Acquired by BD), Sanofi, Pfizer Inc., Stryker Corporation, Cohera Medical, Inc., Kuros Biosciences AG, CryoLife, Inc., Biom'up, Tissuemed Ltd., Misonix, Inc and Other.

The driving factors of the biosurgery market are the rising incidence of chronic diseases and growing demand for minimally invasive surgeries.

North America region will lead the global biosurgery market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client